Lake Hills Wealth Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
AIC
MWA
MAM
FFA
BCG
VFA
BONH
VAG
WAM
FHC
Lake Hills Wealth Management's XBI Position: Q3 2026 in Review
Lake Hills Wealth Management increased its State Street SPDR S&P Biotech ETF (XBI) stake by 0.9% in Q3 2026, buying an estimated $143K and bringing the position to 101,543 shares worth $16M. The position accounts for 7.36% of the portfolio, ranked #3.
Lake Hills Wealth Management first reported a position in XBI in Q2 2024 and has held it in 4 quarters since. 39 funds tracked by Wall St. Rank hold XBI as of Q3 2026.
- Lake Hills Wealth Management held 101,543 shares of State Street SPDR S&P Biotech ETF worth $16M as of Q3 2026.
- Lake Hills Wealth Management bought 907 State Street SPDR S&P Biotech ETF shares in Q3 2026, an estimated $143K.
- State Street SPDR S&P Biotech ETF made up 7.36% of Lake Hills Wealth Management's portfolio in Q3 2026, its #3 holding.
- Lake Hills Wealth Management first reported a position in State Street SPDR S&P Biotech ETF in Q2 2024 and has held it in 4 quarters since.
- 39 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2026.
Based on Lake Hills Wealth Management's 13F filing for Q3 2026, filed 7 Oct 2026.